4//SEC Filing
Marstiller Jean W 4
Accession 0001209191-12-030348
CIK 0001087294other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:48 PM ET
Size
16.7 KB
Accession
0001209191-12-030348
Insider Transaction Report
Form 4
Marstiller Jean W
Sr. VP & Corp. Secretary
Transactions
- Disposition to Issuer
Options
2012-05-22−8,000→ 0 totalExercise: $11.29From: 2010-12-31Exp: 2015-03-26→ Common stock (8,000 underlying) - Disposition to Issuer
Options
2012-05-22−9,000→ 0 totalExercise: $13.00From: 2008-12-31Exp: 2018-07-31→ Common stock (9,000 underlying) - Disposition to Issuer
Options
2012-05-22−12,000→ 0 totalExercise: $11.00From: 2007-12-31Exp: 2017-02-02→ Common stock (12,000 underlying) - Disposition to Issuer
Options
2012-05-22−11,000→ 0 totalExercise: $9.00From: 2006-12-31Exp: 2016-06-30→ Common stock (11,000 underlying) - Disposition to Issuer
Options
2012-05-22−9,000→ 0 totalExercise: $13.00From: 2009-12-31Exp: 2019-02-16→ Common stock (9,000 underlying) - Award
Restricted stock
2012-05-22$6.41/sh+20,946$134,264→ 20,946 totalExercise: $0.00From: 2016-05-22→ Common stock (20,946 underlying)
Footnotes (6)
- [F1]25% vested per year beginning 12/31/09 - 12/31/12
- [F2]25% vested per year beginning 12/31/08 - 12/31/11
- [F3]25% vested per year beginning 12/31/07 - 12/31/10
- [F4]25% vested per year beginning 12/31/06 - 12/31/09
- [F5]Restricted shares acquired in exchange options tendered as part of the Exchange Program that ended on May 21, 2012.
- [F6]Restricted stock does not expire.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001408940
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 5:48 PM ET
- Size
- 16.7 KB